TNF and juvenile idiopathic arthritis: Recently, a particular T lymphocyte population, Th17 cells, has been found to be crucial in JIA pathogenesis: TNF-α inhibitors are the main biological drugs used in JIA and interfere with these cells, giving an explanation of efficacy of etanercept treatment in JIA [25].